News & partners

Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.

Latest news

Sep 08, 2023

Dianosic plans to raise EUR 10m in Series A; to seek exit sale around 2026

See more
Jul 10, 2023

Major Funding Milestone: Dianosic raises 4.7M€ – February 2023

See more
Jul 10, 2023

Dianosic laureate of the i-Lab 2019 innovation contest

See more
Apr 05, 2023

Dianosic x ‌La French Care

See more
Oct 29, 2021

101 Best France Medical Device Startups

See more

They support us

Our investors

We built a solid network of partners to support company funding and growth.

Fondation Force
Bpi France
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est